A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first to show that clinical type 1 diabetes can be delayed by two or more years among people who are at high risk.…
For patients with diabetes, bringing down and maintaining lower blood glucose levels is important to minimize the risk of long-term complications such as nerve damage, kidney damage, an increased risk of heart disease, eye problems, and more. Through a randomized, multicenter clinical trial sponsored by Novo Nordisk, investigators studied blood glucose results for patients assigned…
IMAGE: Dr. Steven Kahn, study chair for the Restoring Insulin Secretion (RISE) Consortium, talks with RISE participant Faamafi Faamafi Jr. about his experience in the adult medication trial. Kahn is an… view more A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in…